NVO — NOVO NORDISK A/S (Healthcare >> Drug Manufacturers - General)
NVO FAQ
What is NVO's P/E ratio?
NOVO NORDISK A/S (NVO) currently trades at a P/E ratio of 1.56.
What is NVO's ROE?
NOVO NORDISK A/S reports a Return on Equity (ROE) of 60.06%.
What is NVO's dividend yield?
NOVO NORDISK A/S offers a dividend yield of 4.20%.
What is NVO's Deepscope Quality Score?
Deepscope rates NVO's overall financial quality at 54 out of 100, based on profitability, growth, debt and earnings stability.
Is now a good time to buy NVO?
Deepscope's AI Timing Score for NVO is 56 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.
Which sector does NVO belong to?
NOVO NORDISK A/S is classified under the Healthcare >> Drug Manufacturers - General sector on the NYSE exchange.
|
USD 42.00
Price
-0.92
(-2.14%)
Day Change
|
|
|---|
NVO Chất lượng tổng thể của cố phiếu Không tốt lắm ( Chất lượng = 54) và Thời điểm mua ...(Sign In to See)...
- Signal
- UNDERPERFORM
- Signal Description
- Company financial health is Not Good
- Reason
-
[-] Tốc độ tăng trưởng ROE dưới mức tiêu chí của chúng tôi.
Tăng trưởng ROE là âm trong năm ngoái.
ROA quá thấp so với ROE
Tốc độ tăng trưởng ROA dưới mức tiêu chí của chúng tôi.
Tăng trưởng ROA dưới mức tiêu chí của chúng tôi trong năm vừa qua
Tốc độ tăng trưởng biên lợi nhuận ròng dưới mức tiêu chí của chúng tôi
88 Sign in
TIMING
- Signal
- OUTPERFORM
- Signal Descri...
- Good
- Reason
- Lorem ipsum dolor sit amet
Chi tiết hơn, sẽ thấy rằng các yếu tố chất lượng Tốt , Sức khỏe tài chính Không tốt lắm , và khả năng kiếm lợi nhuận Tốt , ...
| Yếu tố Chất lượng |
|
73% |
| In Recommendations? | Not in any sections |
| Select Rate | 0.00 From 30 days period |
| Watch Rate | 0.15 From 30 days period |
| News Score | 89 |
| Magic Formula Rank by ROA |
50
GREAT
|
| Magic Formula Rank by ROE |
50
GREAT
|
| Magic Formula Rank by ROIC |
94
GOOD
|
| Price | 42.00 |
| PBV / Sector |
0.94 / 2.77
GREAT
|
| Earning Per Share | 26.94 |
| PE / Sector |
1.56 / 23.60
GREAT
|
| PEG or PE/Growth / Sector |
0.06 / 0.07
GREAT
|
| Average 1M Daily Value |
600.90 M
|
| Average 1W Daily Value |
575.23 M
|
| Yếu tố Kỹ thuật |
|
42% |
| Sức khỏe tài chính |
|
54% |
| Khả năng kiếm lợi nhuận |
|
77% |
| Lợi tức cho nhà đầu tư |
|
62% |
| Chi tiết đăng ký |
| Analyze Date | 2026-06-04 09:24:30 |
| Symbol | NVO |
| Name | NOVO NORDISK A/S |
| Sector | Healthcare >> Drug Manufacturers - General |
| Market | NYSE |
| Listed Shares | 3,355.05 M |
| Par Value | N/A |
| Calculated From | Quarter |
| Sign | N/A |
| Market Cap (M.USD) / Sector Average | 190,132.39 / 232,396.15 |
| Tin tức, Dự báo ước tính |
| Estimation Consensus | See at WSJ.com |
| Full details | See at WSJ.com |
| Chart | See in Chart feature |
| News | See at Yahoo Finance |
Address: Novo Alle 1, Bagsvaerd, Denmark, 2880
Phone: 45 44 44 88 88
Website: https://www.novonordisk.com
Employees: 67,900
Description: Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products. It operates through two segments, Obesity and Diabetes Care, and Rare Disease. The Obesity and Diabetes care segment provides products for diabetes, obesity, cardiovascular, and other emerging therapy areas. The Rare Disease segment offers products in the areas of rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company also provides NovoPen 6 and NovoPen Echo Plus, smart insulin pens; Dose Check, an insulin dose guidance application; growth hormone pens and injection needles; and Wegovy pill an oral glucagon-like peptide-1 (GLP-1) receptor agonist therapy for weight management. It operates in Europe, Canada, the United States, Japan, Korea, Oceania, Southeast Asia, Mainland China, Hong Kong and Taiwan, Latin America, the Middle East, and Africa. Novo Nordisk A/S was founded in 1923 and is headquartered in Bagsvaerd, Denmark.
ME vs SECTOR Healthcare >> Drug Manufacturers - General
Click a bubble to view stock details · Bubble size represents market capitalization share
Google